A retrospective study of Octaplex in the treatment of bleeding in patients with haemophilia A complicated by inhibitors

Blood Coagulation & Fibrinolysis : an International Journal in Haemostasis and Thrombosis
Erik BerntorpJürgen Römisch

Abstract

The nonactivated prothrombin complex concentrate (PCC) Octaplex (Octapharma PPGmbH, Vienna, Austria) has been used successfully for the treatment of congenital and acquired coagulation factor deficiencies and associated bleeding. The aims of this study were to assess retrospectively whether Octaplex is an effective treatment option for haemophilia A patients with high-titre inhibitors of factor VIII (FVIII) and to investigate the impact of Octaplex on thrombin generation in vitro and ex vivo. Retrospective data were collected from 15 haemophilia A patients with FVIII inhibitors who had been treated with Octaplex. Mild bleeds were treated for a median of 1 day with a median dose of 77 IU/kg and moderate bleeds for 3 days with 57 IU/kg. The physician's overall satisfaction with Octaplex, taking into account efficacy, safety and cost in comparison with other treatment options, was assessed for each bleed. The overall rating was good, very good or excellent for 29 of 41 (71%) bleeds. No adverse drug reactions were reported. In in-vitro studies of thrombin generation with normal plasma samples, experimental inhibition of FVIII activity prolonged the lag phase, diminished the peak thrombin concentration and decreased the area under t...Continue Reading

References

Sep 28, 1999·Thrombosis Research·M Köhler
Dec 22, 1999·Haemophilia : the Official Journal of the World Federation of Hemophilia·C A Leissinger
Aug 5, 2000·Seminars in Thrombosis and Hemostasis·J M Lusher
Jun 19, 2002·Blood·Kathleen E BrummelKenneth G Mann
Jul 23, 2003·Journal of Thrombosis and Haemostasis : JTH·K G MannS Butenas
Jul 17, 2004·Current Opinion in Hematology·H Coenraad HemkerSuzette Béguin
Mar 1, 2005·Thrombosis and Haemostasis·Yesim DargaudClaude Negrier
Mar 24, 2005·Clinical and Laboratory Haematology·R J Luddington
Sep 21, 2007·Haemophilia : the Official Journal of the World Federation of Hemophilia·M C OzeloM Karamalis
Nov 17, 2007·Transfusion and Apheresis Science : Official Journal of the World Apheresis Association : Official Journal of the European Society for Haemapheresis·Katharina PockJürgen Römisch
Dec 17, 2008·Seminars in Thrombosis and Hemostasis·Erik Berntorp, Gian Luca Salvagno
Jan 20, 2009·Haemophilia : the Official Journal of the World Federation of Hemophilia·G L SalvagnoE Berntorp
Mar 3, 2009·Transfusion and Apheresis Science : Official Journal of the World Apheresis Association : Official Journal of the European Society for Haemapheresis·Håkon ReikvamTor Hervig

❮ Previous
Next ❯

Citations


❮ Previous
Next ❯

Related Concepts

Related Feeds

Blood Clotting Disorders

Thrombophilia includes conditions with increased tendency for excessive blood clotting. Blood clotting occurs when the body has insufficient amounts of specialized proteins that make blood clot and stop bleeding. Here is the latest research on blood clotting disorders.

Related Papers

Haemophilia : the Official Journal of the World Federation of Hemophilia
C NégrierJ C Bordet
Journal of Thrombosis and Haemostasis : JTH
Maureane Hoffman, Y Dargaud
Haemophilia : the Official Journal of the World Federation of Hemophilia
H H BrackmannW Kreuz
Haemophilia : the Official Journal of the World Federation of Hemophilia
M W HilgartnerDonna M DiMichele
© 2021 Meta ULC. All rights reserved